India Rountree, MD
Dermatology · Mount Pleasant, SCNPI 1962730085
Payments from drug & device makers
Across 305 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$767
- Sanofi$726
- Regeneron Healthcare Solutions, Inc.$564
- Sun Pharmaceutical Industries Inc.$412
- Amgen$383
- plus $1K from 15 others
What the payments were for
- Food & beverage$5,72798%
- Education$872%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 99 | $1,756 |
| Novartis | 49 | $767 |
| Sanofi | 36 | $726 |
| Regeneron Healthcare Solutions, Inc. | 26 | $564 |
| Sun Pharmaceutical Industries Inc. | 26 | $412 |
| Amgen | 18 | $383 |
| Lilly USA, LLC | 13 | $225 |
| Arcutis Biotherapeutics, Inc. | 3 | $211 |
| Mallinckrodt Hospital Products Inc. | 7 | $208 |
| Pfizer | 6 | $130 |
| LEO Pharma Inc. | 5 | $87 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Johnson & Johnson | 5 | $75 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Galderma Laboratories, L.p. | 2 | $28 |
| UCB, Inc. | 1 | $25 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $23 |
| Taro Pharmaceuticals USA, Inc. | 1 | $22 |
| Kerecis Limited | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$5,814 in reported general payments places this provider in the 65th percentile of 203 dermatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 235 | $3,964 |
| Clobetasol Propionate | 62 | $2,857 |
| Metronidazole | 34 | $2,327 |
| Doxycycline Hyclate | 59 | $2,103 |
| Fluorouracil | 23 | $1,980 |
| Ketoconazole | 141 | $1,978 |
| Colchicine | 12 | $1,755 |
| Hydrocortisone | 172 | $1,652 |
| Triamcinolone Acetonide | 184 | $1,532 |
| Mupirocin | 126 | $988 |
| ValacyclovirValacyclovir Hcl | 36 | $897 |
| Hydroxyzine Hcl | 73 | $751 |
| Fluocinolone Acetonide Oil | 13 | $528 |
| Doxepin Hcl | 17 | $198 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Mount Pleasant
- Stephanie Smith-PhillipsMount Pleasant$194K
- Gabriella VasileMount Pleasant$58K
- Todd SchlesingerCharleston$6.4M
- Matthew MillerGreenville$2.8M
- Marshall ShulerGreenville$2.6M
- Rebecca SmithFort Mill$2.3M
- Amylynne FrankelSpartanburg$1.3M
- Theresa KnoeppAnderson$977K
- Jessica BurgyColumbia$519K
- Richard SturtzAnderson$369K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.